🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

88+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 88 recruiting trials for “giant-cell-glioblastoma

Phase 2RecruitingNCT06710249

Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema

🏥 Peter Siesjö📍 1 site📅 Started Jan 2024View details ↗
Phase 1RecruitingNCT05917145

ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma

👨‍⚕️ William G. Breen, MD, Mayo Clinic📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT06924099

TTFields General Routine Clinical Care in ndGBM Patients: a French Prospective Non-Interventional Study (TIGER France)

🏥 NovoCure Ltd.📍 24 sites📅 Started Jan 2024View details ↗
RecruitingNCT06041555

MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)

🏥 Hospices Civils de Lyon📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT06183983

Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma

👨‍⚕️ Alejandra Méndez Romero, MD, PhD, Erasmus Medical Center📍 1 site📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT06220552

The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma

🏥 Fifth Affiliated Hospital, Sun Yat-Sen University📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT05864976

Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning

👨‍⚕️ Dimitrios Mathios, M.D., Washington University School of Medicine📍 1 site📅 Started Dec 2023View details ↗
Phase 1, PHASE2RecruitingNCT07145047

Clinical Study of Oncolytic Virus in Glioblastoma

🏥 Mianyang Central Hospital📍 1 site📅 Started Nov 2023View details ↗
NARecruitingNCT06113705

Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.

👨‍⚕️ Letterio S Politi, MD, Humanitas Research Hospital IRCCS, Rozzano-Milan📍 1 site📅 Started Nov 2023View details ↗
Phase 1RecruitingNCT05577091

Tris-CAR-T Cell Therapy for Recurrent Glioblastoma

👨‍⚕️ Tao Jiang, Prof., Beijing Tiantan Hospital📍 1 site📅 Started Sep 2023View details ↗
Phase 2RecruitingNCT06058988

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

👨‍⚕️ Nelson Moss, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started Sep 2023View details ↗
Phase 1, PHASE2RecruitingNCT06059690

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

👨‍⚕️ Benjamin Ellingson, PhD, University of California at Los Angeles📍 1 site📅 Started Sep 2023View details ↗
Phase 2RecruitingNCT05909618

Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases

👨‍⚕️ Ronnie Shapira Frommer, Dr, Ronnie Shapira, MD Study Principal Investigator Ronnie.Shapira@sheba.health.gov.il📍 1 site📅 Started Jul 2023View details ↗
Phase 1RecruitingNCT05557292

RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma

👨‍⚕️ Nicholas Butowski, MD, University of California, San Francisco📍 1 site📅 Started Apr 2023View details ↗
Phase 1RecruitingNCT05450744

131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)

🏥 Telix Pharmaceuticals (Innovations) Pty Limited📍 6 sites📅 Started Apr 2023View details ↗
NARecruitingNCT05720078

UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)

🏥 Sunnybrook Health Sciences Centre📍 1 site📅 Started Apr 2023View details ↗
Phase 1RecruitingNCT05660369

CARv3-TEAM-E T Cells in Glioblastoma

👨‍⚕️ William Curry, MD, Massachusetts General Hospital📍 1 site📅 Started Mar 2023View details ↗
Phase 1, PHASE2RecruitingNCT05768919

Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas

👨‍⚕️ Matthias Holdhoff, MD, Johns Hopkins University📍 2 sites📅 Started Mar 2023View details ↗
EARLY_Phase 1RecruitingNCT05043701

Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma

👨‍⚕️ Einar O. Vik-Mo, MD, PhD, Oslo University Hospital📍 1 site📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05629702

ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids

👨‍⚕️ Fiona Collinson, MBBS, BSc, MRCP, FRCR, PhD, University of Leeds📍 22 sites📅 Started Feb 2023View details ↗
← PreviousPage 3 of 5Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →